Background {#Sec1}
==========

Microbially produced alkanes have been proposed as potential replacements for the current fossil-derived fuels and chemicals. Alkanes would be ideal substitutes for the currently used fossil fuels, because they can drop in directly in the current infrastructure and engines and have high-energy density and low hygroscopicity, preferred especially in aviation and diesel fuels \[[@CR1], [@CR2]\]. However, realization of alkane production in an environmentally viable way requires that alkanes are produced from sustainable substrates with high efficiency. Currently, most of the microbial alkane production studies have focused on alkane production from biomass-derived sugars. In contrast, carbon dioxide could allow bypassing the biomass step and serve as sustainable carbon source for large-scale production, provided that efficient methods and microbial hosts can be developed for its utilization.

The challenge of alkane production from carbon dioxide can be divided in two parts: (1) the reduction of carbon dioxide to organic compounds, and (2) the conversion of these compounds to long-chain alkanes. These processes impose different, and in part contrasting, requirements for the host metabolism, and are thus regarded difficult to achieve efficiently in any single organism. For example, the most efficient CO~2~ fixation pathways require anaerobic conditions and elevated CO~2~ concentrations \[[@CR3], [@CR4]\]. Due to the anaerobic metabolism, the organisms employing these pathways have limited capacity for the production of highly energy-intensive molecules, such as long-chain alkanes \[[@CR5]\].

Homoacetogenic bacteria (homoacetogens) are known for their ability to efficiently reduce carbon dioxide to acetate by the Wood--Ljungdahl pathway \[[@CR6]\]. The energy for the acetogenesis can be obtained from hydrogen gas, carbon monoxide, synthesis gas, organic compounds, or in the form of electrons directly from the cathode surface of a bioelectrochemical system in a process called microbial electrosynthesis \[[@CR7]--[@CR9]\]. Homoacetogens have been studied for decades and are already being used in industrial scale \[[@CR9]\]. Thus, they present an attractive option for the fixation of carbon dioxide into organic compounds. However, due to the limitations of their anaerobic energy metabolism, they are unlikely to be able to efficiently produce molecules with higher energy content \[[@CR10], [@CR11]\]. Furthermore, metabolic engineering of homoacetogens is hampered by the lack of established gene editing tools. One solution to circumvent these issues and to broaden the metabolic capability is to employ more than one organism in the production system. For example, the acetate produced from CO~2~ by the acetogens can be upgraded to value-added, high-energy molecules by heterotrophic organisms such as *Acinetobacter baylyi* \[[@CR12]\] or *Yarrowia lipolytica* \[[@CR13]\]. Hu et al. produced acetate with *Moorella thermoacetica* from CO~2~ and H~2~, and utilized *Y. lipolytica* for the conversion of the acetate into triacylglycerol. We have previously studied the conversion of acetate produced by acetogens either from CO~2~ and H~2~, or by CO~2~ and electricity (microbial electrosynthesis) into long alkyl chains. In addition, mixed cultures have been utilized for the chain elongation of acetate to higher carboxylic acids, such as caproate and caprylate \[[@CR14]\]. However, alkane production from acetate has not been reported to date.

Alkanes have been produced in various microbial hosts by the heterologous expression of a cyanobacterial two-step pathway. The pathway involves the reduction of fatty acyl-ACP to fatty aldehyde, which is subsequently converted to *n*-alkane. In cyanobacteria, the first step is catalyzed by acyl-ACP reductase (AAR) and the second step by aldehyde deformylating oxygenase (ADO) \[[@CR15]\]. Besides the cyanobacterial AAR homologs, fatty aldehyde-producing reductases have been characterized from various organisms \[[@CR16]--[@CR18]\]. Even though these reductases are not known to participate in alkane production in their native context, they can be utilized as part of synthetic alkane-producing pathways in heterologous hosts. Similarly, an alkane-producing enzyme CER1 from *Arabidopsis thaliana* has been used in heterologous alkane production instead of the cyanobacterial ADOs \[[@CR19], [@CR20]\].

The last enzyme of the pathway, ADO, is regarded as the bottleneck for the alkane biosynthesis, due to its low activity \[[@CR21]\]. Cyanobacteria naturally produce only small amounts of alkanes, and thus the low activity is not an issue in the native context. However, in the (heterologous) overproduction, the low activity of ADO can cause accumulation of the pathway intermediates. Especially the fatty aldehyde, which is the substrate for ADO, is problematic due to its toxic nature \[[@CR22]\]. In addition, endogenous enzymes, such as aldehyde reductases \[[@CR23]\] and dehydrogenases \[[@CR24]\], compete for the fatty aldehyde substrate with ADO, leading to the loss of the valuable long acyl chains from the alkane-producing pathway. Thus, efficient alkane production requires careful balancing of the enzyme activities to provide ADO with sufficient amount of substrate, while avoiding these negative effects of fatty aldehyde accumulation. Furthermore, while the individual components (especially the cyanobacterial AARs and ADOs) of the pathway have been thoroughly studied \[[@CR25]--[@CR27]\], less attention has been paid to the performance of synthetic pathways comprised of enzymes from different origins.

We have previously developed a twin-layer biosensor for the monitoring of the alkane biosynthesis pathway \[[@CR28]\]. The sensor consists of two parts, and is able to monitor both the intermediate fatty aldehyde and the end product alkane. The first part of the sensor consists of constantly expressed bacterial luciferase LuxAB, which utilizes fatty aldehyde as a substrate in a reaction that produces visible light. Thus, the concentration of fatty aldehydes is reflected in the luminescence signal. The second part of the sensor consists of a *gfp* gene under a native alkane-inducible promoter. Both luminescence and fluorescence can be measured in real time during cell growth, making the sensor a powerful tool for the screening and optimization of the alkane biosynthesis pathways in a high-throughput manner.

*Acinetobacter baylyi* ADP1 is a promising chassis for genetic studies, metabolic engineering, and lipid production \[[@CR29]--[@CR33]\]. *A. baylyi* does not naturally produce alkanes, but the fatty aldehyde intermediate is part of its natural storage lipid metabolism \[[@CR34]\], suggesting potential for long-chain alkane production. We have previously shown that alkanes can be produced by the expression of the cyanobacterial pathway (AAR and ADO) \[[@CR28]\]. In addition, *A. baylyi* grows well on acetate, and we have previously shown it to be a suitable chassis for the upgrading of the acetate produced by acetogens into long-chain lipid compounds \[[@CR12]\]. Furthermore, *A. baylyi* ADP1 has tendency for natural transformation and homologous recombination, supporting straightforward genome editing \[[@CR29]\].

In this study, we establish alkane production from acetate in metabolically engineered *A. baylyi* ADP1. By utilizing the alkane biosensor, we compare the performance of different synthetic alkane biosynthesis pathways, and demonstrate the importance of pathway balancing for improved alkane production. Further, we demonstrate the net production of alkanes from CO~2~ and H~2~ by a two-stage bacterial process combining an acetogen *Acetobacterium woodii* and the *A. baylyi* engineered for alkane production (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Outline of the study. Nine synthetic alkane-producing pathways were constructed from genetic parts originating from different species (**a**). The performance of these pathways in alkane production from acetate was evaluated by a previously developed twin-layer sensor (**b**), which allows the detection of both the pathway intermediate (fatty aldehyde) and the end product (alkane). The engineered strain that produced most alkanes was coupled with a process in which acetate was produced from carbon dioxide by acetogenic bacteria, leading to the net production of alkanes from carbon dioxide (**c**)

Results {#Sec2}
=======

As the first step towards the alkane production from CO~2~, we started by constructing nine synthetic alkane biosynthesis pathways and compared their performance in alkane production from acetate. We have previously demonstrated increased fatty aldehyde production in *A. baylyi* with the expression of any of the three different reductases: Acr1, AAR and a putative dehydrogenase from *Nevskia ramosa*, designated here as Ramo \[[@CR35]\]. Acr1 is an endogenous fatty acyl-CoA reductase from *A. baylyi* that is involved in the natural storage lipid (wax ester) production pathway. AAR from *Synechococcus elongatus* is a fatty acyl-ACP/CoA reductase employed in the alkane production pathway in cyanobacteria, and earlier studies indicate that it is the most efficient among the cyanobacterial homologs \[[@CR25]\]. Ramo, on the other hand, is a putative short-chain dehydrogenase from the bacterium *Nevskia ramosa*. Ramo was initially identified based on its sequence homology with Acr1, and its expression was shown to increase the fatty aldehyde and wax ester production in *A. baylyi* \[[@CR35]\]. These three fatty aldehyde-producing enzymes were included in this study. The alkane-producing enzymes selected for the study were ADOs from *Synechococcus elongatus* (SeADO) and *Prochlorococcus marinus* (PmADO), and CER1 from *Arabidopsis thaliana*, all of which have been previously utilized in heterologous alkane production \[[@CR15], [@CR20]\].

The genes encoding the pathway enzymes were cloned under T5/*lac* promoter as synthetic operons containing first the alkane-producing and then the aldehyde-producing gene, both preceded by ribosomal binding site (RBS) sequences (Fig. [1](#Fig1){ref-type="fig"}b). The resulting nine constructs were transformed to the previously developed biosensor strain \[[@CR28]\]. *A. baylyi* naturally degrades alkanes, but the *alkM* gene essential for alkane degradation \[[@CR36]\] has been deleted from the sensor strain \[[@CR28]\].

For the comparison of alkane production, the sensor cells harboring the different pathways were cultivated in 96-well plate in minimal medium supplemented with 50 mM acetate. The expression of the alkane biosynthesis genes was induced with either 10 or 100 µM IPTG and the luminescence and fluorescence signals measured in real time during cell growth (Fig. [2](#Fig2){ref-type="fig"}). The highest luminescence signal, indicating highest fatty aldehyde production, was obtained with the CER1-AAR pair. On the contrary, the highest fluorescence signal, indicating the highest alkane production, was obtained with SeADO-AAR pair with the 100 µM IPTG induction. This pair was selected for further studies.Fig. 2Comparison of the synthetic pathways. The sensor cells containing different alkane biosynthesis pathways were cultivated in minimal medium with 50 mM acetate. The expression of the alkane biosynthesis genes was induced with 10 or 100 µM IPTG, and the luminescence (upper panel) and fluorescence (lower panel) signals produced by the sensor cells were measured. The cumulative luminescence signal reflects the amount of fatty aldehyde produced by the cells throughout the cultivation (relative to the control), and the relative fluorescence signal reflects the activation of the *gfp* expression in response to the alkanes produced by the cells. The negative control strain is the sensor strain without the alkane biosynthesis pathway. Average and standard deviation of two replicates are shown

Optimal production requires that the enzyme activities in the pathway are balanced, thus avoiding the accumulation of intermediates while maintaining high flux through the pathway. Thus, we next set out to optimize the relative expression levels of ADO and AAR. Changes in the relative expression were achieved by modulating the RBS of AAR in the synthetic operon. Three RBS:s with predicted strengths "weak", "medium" and "strong" based on *E. coli* characterization were chosen (Biobrick parts BBa_0031, BBa_0032, and BBa_0030, respectively). The original strong RBS (BBa_0034) of ADO was not changed. The three synthetic operons with varying AAR RBSs were again expressed in the sensor strain. The cells were cultivated in the 96-well plate, and luminescence and fluorescence measured in real time. As expected, the highest luminescence signal was obtained with the strongest RBS, indicating that the highest expression level of AAR led to the highest fatty aldehyde production (Fig. [3](#Fig3){ref-type="fig"}, upper panel). In contrast, the highest fluorescence signal was obtained with the intermediate strength RBS, suggesting that relatively lower expression of AAR leads to more balanced metabolism and higher alkane production (Fig. [3](#Fig3){ref-type="fig"}, lower panel). Thus, this strain was utilized in the subsequent alkane production experiments.Fig. 3Balancing the relative expression levels of ADO and AAR. The alkane biosynthesis pathway consisting of SeADO and AAR was balanced by altering the ribosomal binding site (RBS) of AAR, while the RBS of SeADO was remained unchanged (strong). The sensor cells harboring the pathways with different RBS strengths were cultivated in minimal medium with 50 mM acetate. The expression of the alkane biosynthesis genes was induced with 10 or 100 µM IPTG, and the luminescence (upper panel) and fluorescence (lower panel) signals were measured. The cumulative luminescence signal reflects the amount of fatty aldehyde produced by the cells throughout the cultivation (relative to the control), and the relative fluorescence signal reflects the activation of the *gfp* expression in response to the alkanes produced by the cells. The negative control strain is the sensor strain without the alkane biosynthesis pathway. Average and standard deviation of two replicates are shown

The application of acetate as the substrate in high concentrations is restrained by its growth-inhibiting nature \[[@CR37]\]. Although *A. baylyi* grows well on reasonably high acetate concentrations \[[@CR12], [@CR38]\], carbon limitation is still inevitable in batch cultivations. To circumvent this issue and allow higher growth and alkane production, we next established a fed-batch cultivation strategy in a 1-L benchtop bioreactor. The engineered alkane production strain was cultivated in the reactor in minimal medium. The cultivation was initiated with a batch phase in 500 mL of the medium with 0.2% casein amino acids as the sole carbon source. After that, the expression of the alkane biosynthesis operon was induced with 100 µM IPTG and the feed initiated. The feed solution contained 80 g/L acetic acid, and the rate was manually controlled to keep the acetate concentration in the reactor between 30 and 60 mM to avoid carbon limitation. The cultivation was continued for 25 h after the beginning of the feed, and cell growth, acetate consumption, and alkane production were monitored (Fig. [4](#Fig4){ref-type="fig"}). During the cultivation, the cells consumed approximately 290 mmol acetate (Fig. [4](#Fig4){ref-type="fig"}). The cells produced approximately 1.6 µmol heptadecane, the final titer being 540 µg/L \[productivity 21 µg/(L\*h) and yield (carbon/carbon) 0.005%\].Fig. 4Alkane production from acetate. The selected alkane-producing *A. baylyi* strain was cultivated in a bioreactor in minimal salts medium in fed-batch mode. The feed contained 80 g/L acetic acid, and the feed rate was manually controlled to keep the acetate concentration in the reactor between 30 and 60 mM. Acetate consumption was calculated based on the measured acetate concentrations in the reactor and the volume of the acetic acid solution fed to the reactor

Acetogens are known for their ability to efficiently reduce carbon dioxide to acetate. To achieve alkane production from carbon dioxide, we employed the acetogen *A. woodii* for the production of acetate from CO~2~ and H~2~. *A. woodii* was grown in a bioreactor in 600 mL of minimal medium, and the medium was continuously flushed with H~2~/CO~2~ gas. In addition, the medium was supplemented with 4 g/L yeast extract to support the growth of *A. woodii*. The yeast extract is expected to contribute only to biomass formation and not to acetate production, as demonstrated earlier \[[@CR39]\]. During a 6-day cultivation, *A. woodii* grew to an optical density of 2.3 and produced approximately 190 mM acetate (Fig. [5](#Fig5){ref-type="fig"}a). The medium from this cultivation, including the *A. woodii* biomass, was used as the feed for the alkane-producing *A. baylyi* as such. *A. baylyi* was grown in a bioreactor similarly as earlier. After the initial batch phase with 0.2% casein amino acids as the carbon source, the feed was initiated, and the alkane production induced with 100 µM IPTG. The rate of the feed was manually controlled to keep the acetate concentration in the reactor between 30 and 70 mM. Due to the relatively dilute feed, the volume of the cultivation increased from an initial 300 mL to the final 800 mL. *A. baylyi* utilized the feed for growth and alkane production (Fig. [5](#Fig5){ref-type="fig"}b), resulting in the net production of alkanes from CO~2~ and H~2~. During the 9-h cultivation, *A. baylyi* produced 0.25 µmol heptadecane, the final titer being 74 µg/L \[productivity 8.2 µg/(L\*h)\], and consumed approximately 74 mmol of acetate (carbon/carbon yield 0.003%).Fig. 5Alkane production from CO~2~ and H~2~. *Acetobacterium woodii* was grown with CO~2~ and H~2~, and cell growth and acetate production were measured (**a**). After 6 days, the acetate-containing *A. woodii* medium was used as the feed for alkane-producing *A. baylyi* in fed-batch culture (**b**). The feed rate was manually controlled to keep the acetate concentration in the medium between 30 and 70 mM. *A. baylyi* utilized the feed for growth and alkane production (**b**). Due to the relatively dilute feed (containing approximately 190 mM acetate), the culture volume of the *A. baylyi* cultivation increased from 300 to 800 mL during the process

Discussion {#Sec3}
==========

In the production of bulk chemicals, such as liquid fuels, required in massive quantities, the sustainability of the raw material is of special importance. Carbon dioxide would be an ideal carbon source due to its abundance, independency of land usage, and the urgent need to limit its concentration in the atmosphere \[[@CR40]\]. On the other hand, alkanes could serve as drop-in replacements to current fossil-derived liquid fuels. Microbes hold potential for both the production of alkanes, and the reduction of CO~2~, but significant advancements are required to establish an efficient microbial process for the conversion of CO~2~ to alkanes.

In this study, we demonstrated the microbial production of alkanes from CO~2~ and H~2~ by a system combining the strengths of two different bacterial species. For the CO~2~ reduction, we employed the acetogen *A. woodii*, which is able to efficiently produce acetate from CO~2~ and H~2~ \[[@CR39]\]. To convert the acetate to alkanes, and to achieve the net production of alkanes from CO~2~, we studied heterologous alkane production in *A. baylyi* ADP1, which has been previously used to upgrade acetate to long-chain lipid molecules \[[@CR12]\]. *A. baylyi* does not naturally produce alkanes, but we have previously demonstrated alkane production by the heterologous expression of the two-step cyanobacterial pathway \[[@CR28]\]. In this study, we utilized the previously developed alkane biosensor \[[@CR28]\] for the evaluation and optimization of different synthetic alkane-producing pathways. The native fatty acyl-CoA reductase Acr1 has been deleted from the sensor strain, thus disrupting the native wax ester synthesis pathway \[[@CR28]\].

Microbial alkane production can be achieved in heterologous hosts by the expression of aldehyde-producing fatty acyl-CoA/ACP reductase (AAR) and aldehyde deformylating oxygenase (ADO) \[[@CR41]\]. We have previously found that the fatty aldehydes produced in *A. baylyi* may have different metabolic fates depending on the reductase that is producing them. Specifically, the aldehydes produced by Acr1 or Ramo were efficiently directed to fatty alcohols and further to wax esters by native *A. baylyi* enzymes, but the aldehydes produced by cyanobacterial AAR were not \[[@CR35]\]. Furthermore, it has been speculated previously that the cyanobacterial AAR and ADO might interact with each other and thus ensure efficient delivery of the fatty aldehyde from AAR to ADO \[[@CR27]\]. Thus, it is reasonable to assume that there might be differences in the efficiency of the aldehyde delivery from AAR to ADO in synthetic pathways utilizing enzymes originating from different species. To investigate the function of alkane biosynthesis pathways consisting of different enzymes, we started by constructing and comparing nine synthetic pathways that comprised of different aldehyde- and alkane-producing enzymes.

For the comparison of the synthetic pathways, we utilized the previously developed twin-layer alkane biosensor, which allows the monitoring of both the aldehyde intermediate and the end product alkane. The monitoring of the aldehyde intermediate, in addition to the end product alkane, yields valuable information about the functionality of the aldehyde-producing enzymes in this context, and enables rational evaluation of potential pathway bottlenecks. Three aldehyde-producing reductases (AAR, Acr1, Ramo) and three alkane-producing enzymes (SeADO, PmADO, CER1) were selected for the study. The expression of any of the aldehyde-producing reductases in combination with any of the alkane-producing enzymes was associated with aldehyde production, as measured by the biosensor. The results are in agreement with our earlier study, where the fatty aldehyde production was increased in *A. baylyi* by the overexpression of any of these reductases \[[@CR35]\].

Based on the biosensor output, there are significant differences on the efficiency of alkane production from the aldehydes depending on the enzyme pair. The combination of CER1-AAR led to the highest aldehyde production, whereas the SeADO-AAR pair led to the highest alkane production. Interestingly, alkane production by SeADO was significantly higher when AAR was used to provide the aldehydes, than with the other two reductases (Acr1 or Ramo). With the other two alkane-producing enzymes (PmADO, and CER1), the difference was not so clear, and they seem to accept the aldehydes equally well from any of the reductases tested.

For synthetic pathways to work efficiently, the enzyme activities need to be balanced to avoid the accumulation of pathway intermediates and the metabolic burden caused by unnecessary high protein expression \[[@CR42]\]. In the case of the alkane biosynthesis pathway, the relatively low activity of ADO compared to AAR may lead to the accumulation of the fatty aldehyde, potentially hampering the efficiency of alkane production. Thus, we next set out to balance the relative expression of ADO and AAR for improved alkane production. The relative expression of AAR was altered by modifying the strength of the RBS, and the effects on the aldehyde and alkane production were measured with the biosensor. The strongest RBS yielded the highest aldehyde production, as expected. In contrast, the alkane production was higher when an RBS with intermediate strength was used. This suggests that lowering the AAR expression leads to more balanced metabolism, thus avoiding the harmful effects of the fatty aldehyde accumulation, and resulting in higher alkane production. This result is in agreement with a recent study, where it was concluded that the accumulation of fatty aldehydes was not beneficial for the alkane production in *E. coli* \[[@CR43]\].

The RBSs utilized in this study have not been previously characterized in *A. baylyi*. The luminescence signal of the biosensor is expected to correlate with the aldehyde production \[[@CR28]\]. As the RBS modification was applied to the aldehyde-producing part (AAR) of the pathway, the luminescence signal could be used to estimate the strength of each RBS in *A. baylyi*. The "strong" RBS resulted in the production of approximately five-fold stronger luminescence signal, as compared to the "weak" RBS. On the other hand, the signal produced with the "medium" RBS was similar to that of the "weak". Further development and characterization of RBS toolbox with wider range would benefit the metabolic engineering of *A. baylyi*.

Alkane biosensors have been suggested as a potential tool for speeding up the strain development and the screening of novel and/or altered enzymes for alkane production \[[@CR41]\]. Even though various alkane biosensors have been developed \[[@CR28], [@CR44], [@CR45]\], this is the first time a sensor is used for the evaluation of the performance of different pathway configurations. The twin-layer sensor utilized here allows the monitoring of both the key intermediate and the end product of the alkane biosynthesis pathway, offering insights into the function of the pathway. The successful utilization of the sensor for the pathway balancing exemplifies the benefits of biosensors in the development of efficient production strains.

In many microbes, including *A. baylyi*, efficient lipid production is promoted by an excess of the carbon source. Typically, favorable conditions are achieved by maintaining a high carbon-to-nitrogen ratio in the culture medium. With acetate, however, high concentrations are not feasible due to its toxicity. Consequently, batch cultivations are rapidly depleted of acetate, leading to carbon limitation and inefficient lipid production. In this study, we utilized a fed-batch cultivation strategy to support better growth and alkane production from acetate. In the cultivations, acetate concentration was maintained between 30 and 70 mM to provide the cells with sufficient carbon and energy source while avoiding the toxic effects of higher concentrations. With this strategy, alkanes could be produced both from pure acetic acid and from the acetic acid produced by the acetogen *A. woodii*. In our experiments, the alkane production was more efficient when pure acetic acid was used as the feed when compared to the medium from the acetogenic cultivation. One explanation is that the used medium also contained the biomass of *A. woodii*, leading to relatively lower carbon-to-nitrogen ratio, potentially negatively effecting the alkane production.

We have previously studied wax ester (WE) production from acetate in *A. baylyi* \[[@CR12]\]. WEs are produced from the same intermediates that are used in the alkane production pathway (fatty aldehyde and fatty acyl-CoA), and thus it is interesting to compare the efficiency of WE and alkane production. The WE titer from acetate (ca. 90 mg/L, \[[@CR12]\]) was significantly higher than the alkane titer in the present study (\< 1 mg/L), suggesting that the precursor supply is not limiting the alkane production even in the relatively low-carbon conditions. This implies that future research should focus on improving the last step (conversion of fatty aldehydes to alkanes) in the alkane production pathway. For example, the activity of ADO may be improved by the coexpression of an electron transfer system \[[@CR46]\].

Acetate is a platform chemical that can be produced from CO~2~ by various microbial processes, such as microbial electrosynthesis or syngas fermentation. Throughout this study we utilized acetate as the carbon source for alkane production to allow the connection of the alkane-producing module to an upstream acetate-producing module. As a proof of principle, in the final stage of this study, we connected the alkane production with the upstream acetate production from CO~2~ by the acetogen *A. woodii*. The two-stage production system converges around acetate, and enables the construction of versatile processes by plugging different acetate-producing and -consuming modules in the system. For example, the final product can be modified by engineering the production host. We have previously studied the wax ester production from acetate produced by the acetogens \[[@CR12]\], while other studies have reported the production of triacylglycerides \[[@CR13]\], alcohols \[[@CR47]\], or *n*-butanol, polyhydroxybutyrate, and isoprenoids \[[@CR48]\]. In this study, aliphatic long-chain alkane production from acetate was demonstrated, further expanding the product range to hydrocarbons, enabling the production of drop-in replacements for liquid fuels.

Even though the production of heptadecane from CO~2~ was demonstrated in this proof-of-concept study, the low titers and productivities achieved underline the challenges related to the production of long-chain hydrocarbons. The highest microbial alkane production titers have been reported with engineered *E. coli*, exceeding 2 g/L \[[@CR49]\]. However, these titers have been achieved with more favorable carbon sources, such as glucose. Acetate produced by acetogens could serve as a more sustainable carbon source, but alkane production from acetate has not been previously studied. *A. baylyi* is proposed as a potent host for the hydrocarbon production from acetate due to its relatively high growth rate on acetate, the tendency for storage lipid accumulation, and its amenability to genetic engineering \[[@CR12], [@CR29], [@CR32], [@CR38]\]. In this study, the first steps in improving heterologous alkane production in *A. baylyi* were taken. However, to realize efficient alkane production from CO~2~, significant improvement in the alkane production efficiency along with bioprocess optimization is required. The previous study describing alkane production from CO~2~ and H~2~, using engineered bacterium *Cupriavidus neacator*, reported the production of 4.4 mg/L alkanes, highlighting the difficulty of obtaining high titers with cumbersome substrates \[[@CR50]\].

The modular nature of the two-stage production system brings the additional advantage that both the CO~2~ fixation and alkane production can be optimized independently of each other. For example, significantly higher acetate production rates have been obtained with *A. woodii* with optimized reactor design \[[@CR39]\] or metabolic engineering \[[@CR51]\]. In this work, we focused on the alkane production from acetate by *A. baylyi*, but the overall productivity and titer of the system could be enhanced by optimizing both modules. As an easy-to-engineer chassis, *A. baylyi* can potentially be utilized for the production of a range of compounds, further emphasizing the modular nature of the system.

Conclusions {#Sec4}
===========

In this study, we engineered *A. baylyi* ADP1 for the non-native production of alkanes from acetate. The performance of nine different synthetic pathways was compared with a twin-layer biosensor capable of detecting both the intermediate (fatty aldehyde) and the end product (alkane) of the pathway. The utilization of the twin-layer biosensor enabled the balancing of the pathway to avoid the accumulation of the intermediate fatty aldehyde, which led to improved alkane production. Even though the alkane titers remained low, the successful application of the biosensor in improving the heterologous alkane biosynthesis encourages further research. This was the first demonstration of alkane production from acetate, and enabled the connection of the alkane-producing module to an upstream acetate production from CO~2~ and H~2~ by acetogenic bacteria, thereby leading to the net production of long-chain alkane from CO~2~ and H~2~.

Methods {#Sec5}
=======

Bacterial strains and genetic modifications {#Sec6}
-------------------------------------------

The previously described alkane biosensor (ASI) constructed in *A. baylyi* ADP1 (DSM 24139) \[[@CR28]\] was used for the construction of alkane-producing strains. For molecular cloning and plasmid maintenance, *Escherichia coli* XL1-Blue (Stratagene, USA) were used. *Acetobacterium woodii* (DSM 1030) was ordered from Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ).

For the expression of the alkane biosynthetic genes, a previously described expression cassette was used \[[@CR35]\]. The cassette contains an IPTG-inducible T5/*lac* promoter, followed by the *lacI* gene and the Biobrick RFC10-accepting cloning site (*Eco*RI--*Xba*I--*Spe*I--*Pst*I) (Fig. [1](#Fig1){ref-type="fig"}b). The cassette also contains a spectinomycin resistance marker gene under its own promoter, and flanking sites to facilitate the integration of the cassette to the prophage region of *A. baylyi* \[[@CR52]\]. *Acr1* (ACIAD3383) was amplified from the genome of *A. baylyi* ADP1 and *Ramo* (an open reading frame encoding for a putative short-chain dehydrogenase WP_022976613.1) from the genome of *Nevskia ramosa* (DSM 11499) with primers tl17 and tl18 and tl33 and tl34, respectively (Table [1](#Tab1){ref-type="table"}). A*ar (S. elongatus aar,* WP_011242364.1*), seado* (*S. elongatus ado*, WP_011378104.1)*, pmado* (*P. marinus ado*, WP_011130600.1) and *cer1* (*Arabidopsis thaliana*, NP_001184890.1) were codon-optimized and purchased from Genscript (USA) with appropriate restriction sites and ribosomal binding sites (Biobrick part BBa_0034). The nucleotide sequences of the genes are provided in the Additional file [1](#MOESM1){ref-type="media"}. These ADO and AAR analogs were sequentially cloned to the expression cassette using the Biobrick RFC10 protocol to produce nine different combinations. For the RBS modulation, the *aar* gene was PCR-amplified with the primers containing the appropriate RBS sequences (Table [1](#Tab1){ref-type="table"}), and cloned to the *seado*-containing expression cassette. The expression cassettes were transformed to the alkane biosensor strain by natural transformation as described previously \[[@CR32]\], and colonies were selected with 50 µg/L spectinomycin. All genetic modifications were confirmed with PCR and sequencing.Table 1Primers used in the studyNameSequence 5′ → 3′Descriptiontl17TGGAATTCGCGGCCGCTTCTAGAGAAAGAGGAGAAATACTAGATGATATCAATCAGGGAAAAACGCGacr1 forward, biobricktl18GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTACCAGTGTTCGCCTGGGacr1 reverse, biobricktl33CGGCCGCTTCTAGAGAAAGAGGAGAAATACTAGATGAATTACTTCGTCACCGGramo forward, XbaItl34GGCCGCTACTAGTATTATTACCAATGCTCGCCCTTGramo reverse, SpeI0030_AarTGGAATTCGCGGCCGCTTCTAGAGATTAAAGAGGAGAAATACTAGATGTTTGGTTTAATTGGCCAaar forward, BBa0030, biobrick0031_AarTGGAATTCGCGGCCGCTTCTAGAGTCACACAGGAAACCTACTAGATGTTTGGTTTAATTGGCCAaar forward, BBa0031, biobrick0032_AarTGGAATTCGCGGCCGCTTCTAGAGTCACACAGGAAAGTACTAGATGTTTGGTTTAATTGGCCAaar forward, BBa0033, biobrickAar_revCTGCAGCGGCCGCTACTAGTATTATTAAATTGCTAAAGCCAGCGaar reverse, biobrick

Medium and culture conditions {#Sec7}
-----------------------------

Cloning and routine maintenance of *A. baylyi* and *E. coli* were performed in LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl). In alkane production experiments, *A. baylyi* were cultivated in modified minimal salts medium MA/9. The medium contained (per liter): 5.52 g Na~2~HPO~4~\*2H~2~O, 3.4 g KH~2~PO~4~, 1 g NH~4~Cl, 2 g casein amino acids, 0.008 g nitrilotriacetic acid, 2.0 mg FeCl~3~, 11.1 mg CaCl~2~, and 240 mg MgSO~4~. Acetic acid was used as the carbon source in concentrations indicated in the results section. IPTG (isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside) was used for the induction of the alkane biosynthesis genes in concentrations indicated in "[Results](#Sec2){ref-type="sec"}" section. Spectinomycin (50 µg/mL) was used for selection.

For the real-time in vivo luminescence and fluorescence measurements, the cells were cultivated in 96-well plate (Greiner Bio-one, Austria) in Spark microplate reader (Tecan, Switzerland). The cells were inoculated from overnight culture to an initial optical density of approximately 0.05 and cultivated in 200 µL of medium. The plate was placed inside a humidity cassette (Tecan) to prevent evaporation. The cultivation and measurement were performed at 30 °C. Optical density (600 nm), luminescence and fluorescence (excitation 485 ± 10 nm, emission 510 ± 5 nm) signals were measured every 30 min, and the plate was shaken for 5 min twice an hour (108 rpm, 2.5 mm amplitude). The relative fluorescence values were obtained by dividing the fluorescence reading with the optical density. The cumulative luminescence values were calculated by adding all the luminescence readings together.

*Acetobacterium woodii* was grown in DSM 135 medium containing (per liter): 1 g NH~4~Cl, 0.33 g KH~2~PO~4~, 0.45 g K~2~HPO~4~, 0.1 g MgSO~4~ × 7H~2~O, 2 g yeast extract, 10 g NaHCO~3~, 10 g [d]{.smallcaps}-fructose, 0.5 g [l]{.smallcaps}-cysteine-HCl, 30 mg nitrilotriacetic acid, 60 mg MgSO~4~ × 7H~2~O, 10 mg MnSO~4~ × H~2~O, 20 mg NaCl, 2 mg FeSO~4~ × 7H~2~O, 3.6 mg CoSO~4~ × 7H~2~O, 2 mg CaCl~2~ × 2H~2~O, 3.6 mg ZnSO~4~ × 7H~2~O, 0.2 mg CuSO~4~ × 5H~2~O, 0.4 mg KAl(SO~4~)~2~ × 12H~2~O, 0.2 mg H~3~BO~3~, 0.2 mg Na~2~MoO~4~ × 2H~2~O, 0.6 mg NiCl~2~ × 6H~2~O, 6 µg Na~2~SeO~3~ × 5H~2~O, 8 µg Na~2~WO~4~ × 2H~2~O, 20 µg biotin, 20 µg folic acid, 100 µg pyridoxine--HCl, 50 µg Thiamine--HCl × 2H~2~O, 50 µg riboflavin, 50 µg nicotinic acid, 50 µg [d]{.smallcaps}-Ca-pantothenate, 1 µg vitamin B12, 50 µg *p*-aminobenzoic acid, and 50 µg lipoic acid. For autotrophic growth with CO~2~, fructose was omitted, the concentration of yeast extract increased to 4 g/L and NaHCO~3~ decreased to 5 g/L \[[@CR39]\].

Bioreactor {#Sec8}
----------

The bioreactor cultivations were carried out in 1-L vessel (Sartorius Biostat B plus Twin System, Germany) with a working volume of 600 mL (*A. woodii*) or 300--800 mL (*A. baylyi*), as indicated in the results section. pH was controlled to 7.0 by automated addition of 1 M H~3~PO~4~ or 5 M KOH. Temperature was kept at 30 °C and stirring speed at 300 rpm. For the *A. baylyi* cultivations, air was supplied at 1 L/min, and partial oxygen pressure controlled to 20% saturation by supply of oxygen. For *A. woodii* cultivations, the reactor was operated at anaerobic conditions, and a mixture of H~2~ and CO~2~ (80%/20%) was purged through the system at 1 L/min.

Analytical methods {#Sec9}
------------------

Acetate concentrations were measured with high-performance liquid chromatography using LC-20AC prominence liquid chromatograph (Shimadzu, Japan) and Rezex RHM-Monosaccharide H+ (8%) column (Phenomenex, USA) with 5 mM H~2~SO~4~ as the mobile phase.

Hydrocarbon extraction and analysis was performed as described earlier \[[@CR28]\]. Briefly, cells from 10 mL of the culture were collected by centrifugation, and lipids extracted with methanol--chloroform extraction. The chloroform phase was analyzed by gas chromatography--mass spectrometry (GC--MS). The GC--MS analysis was performed with Agilent Technologies 6890N/5975B system, column HP-5MS 30 m × 0.25 mm with 0.25 µm film thickness, He flow 4.7 mL/min, 1 µL splitless injection, oven program: 55 °C hold 5 min, 55--280 °C 20°/min ramp, 280 °C hold 3 min. Scan 50--500 *m*/*z*, 1.68 scan/s. Heptadecane peaks were identified and quantified based on external standard (Sigma-Aldrich, USA).
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